Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy

摘要

Objective To determine the efficacy of antibacterial prophylaxis in preventing infectious complications after percutaneous endoscopic gastrostomy. Design Prospective, randomised, placebo controlled, Double blind, multicentre study. Setting departments of internal medicine at six German hospitals. Subjects Of 106 randomised adult patients with Dysphagia, 97 received study medication, and 84 Completed the study. The median age o the patients Was 65 years.